Venture Partner, OrbiMed Advisors
CEO and Founder, ExploraMed Development
Director, Stanford University Artificial Intelligence Laboratory
Founder, New Tech Colorado
CEO and Co-Founder, Endeavor
General Partner, Matrix Partners
Professor of Genetics, Harvard Medical School
Professor, Laboratory of Genetics, Salk Institute
|
|
How hard is it to detect and analyze individual circulating tumor cells? Find out what’s next in cancer diagnostics and why such work has the potential to revolutionize how cancer is diagnosed and treated. Invited speakers are Peter Kuhn, a professor at the Scripps Research Institute, and Thomas Broudy, chief scientific officer at Molecular Response. Event is free, but please register online here.